A Review on Diabetes Mellitus
Résumé fourni par la source
“Diabetes mellitus” is one of the most prevalent non-communicable diseases in the world. Diabetes mellitus is the most common endocrine disorder that impairs the body's capacity to produce or utilize insulin. Conventionally, diabetes has been divided into three types, Type 1 DM, or insulin-dependent diabetes mellitus (IDDM), in which the body fails to produce insulin and presently requires the person must inject insulin or use an insulin pump. This is also termed "juvenile diabetes." Type 2 DM, or non-insulin-dependent diabetes mellitus (NIDDM), results from insulin resistance, a condition in which cells fail to use insulin properly, with or without an absolute insulin deficiency. This type was previously referred to as "adult-onset diabetes." The third main type is gestational diabetes, which occurs when women without a previous history of diabetes develop a high blood glucose level during their pregnancy. It may precede the development of type 2 DM. A person with diabetes mellitus (DM), also known as simply diabetes, has an excessive blood sugar level over a prolonged period due to chronic metabolic diseases caused by insufficient insulin production by the pancreas or ineffective insulin uptake or response by the body's cells. People managing diabetes encounter a number of obstacles, such as the disease's increasing incidence in both urban and rural areas, low disease knowledge, a shortage of medical facilities, expensive treatment, inadequate glycemic control, and an increase in the frequency of diabetic complications. Typically, subcutaneous injections are used to deliver insulin therapy for diabetes, up to four times per day. Long-term insulin therapy has led to issues with patient compliance, which has an impact on patient outcomes. These issues are further exacerbated by the intrusive nature of insulin delivery. Type 2 diabetes mellitus, which accounts for more than 90% of all diabetes occurrences, is the primary cause of the diabetic epidemic, while type 1 diabetes incidence is also on the rise.
Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.
Contrôle bibliographique ouvert
DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.
- Titre Crossref
- A Review on Diabetes Mellitus
- Date Crossref
- 01/01/2024
- Éditeur
- SUNTEXT REVIEWS LLC
- Type
- journal-article
Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude et ne compte pas comme une seconde source scientifique indépendante.